期刊文献+

眼内免疫调节因子 被引量:1

Immune regulatory factors within the eye
下载PDF
导出
摘要 眼免疫赦免是一个主动的调节过程,除了眼部解剖特征以及眼实质细胞构成性表达Fas配体、膜结合性补体之外,其局部的免疫抑制微环境在眼免疫赦免的形成中起了重要的作用。眼微环境中含有多种潜在的免疫调节因子,其免疫抑制活性成分可分成相对分子质量为3 000~5 000和小于3 000两部分。这些细胞因子通过调节眼部抗原递呈、抑制炎症因子等作用诱导前房相关免疫偏离,从而避免眼发生免疫性炎症。 Ocular immune privilege (IP) is an active process.Besides anatomic factors and constitutive expression of cell surface molecules such as Fas Ligand and inhibitors of complement,the immune suppressive microenvironment play an important role in the maintenance of IP.The factors that contribute to this microenvironment include two parts:proteins with a molecular weight between 3 000~5 000 and those with low molecular weight (<3 000).These factors modulate the antigen processing within the eye and inhibit the generation of inflammation mediators,therefore leading to the induction of anterior chamber associated immune deviation.It is well proved that IP within the eye is an important mechanism to prevent the development of intraocular inflammation.
作者 傅涛
出处 《眼科研究》 CSCD 北大核心 2002年第1期92-94,共3页 Chinese Ophthalmic Research
基金 国家杰出青年基金(39925034) 教育部跨世纪人才基金 广东省重点科技公关项目基金资助
关键词 免疫郝免 免疫偏离 免疫调控 免疫调节因子 immune privilege immune deviation immune regulation
  • 相关文献

参考文献18

  • 1[1]Hara Y,Okamoto S,Rouse B,et al.J Immunol,1993,151∶5162
  • 2[2]Thomas JD,Niederkorn JY.J Immunol,1998,160∶2089
  • 3[3]Kosiewicz MM,Pascale A,Streilein JW.J Immunol,1998,161∶5382
  • 4[4]Takeuchi M,Alard P,Verbik D,et al.Immunol,1999,98∶576
  • 5[5]Lipton JM.Yale J Biol Med,1990,63∶173
  • 6[6]Taylor AW,Strelein JW,Cousins SW.J Immunol,1994,153∶1080
  • 7[7]Kahn M,Kaplan H,Ferguson T.Arch Virol,1993,131∶115
  • 8[8]Ferguson TA,Fletcher S,Herndon J,et al.J Immunol,1995,155∶1746
  • 9[9]ang ZY,Alm P,Haskanson R.Br J Pharmacol,1996,118∶1537
  • 10[10]Richard AS,Alice MM.Invest Ophthalmol Vis Sci,1988,29∶305

同被引文献30

  • 1董秋梅,阎小萍.白塞病的中医病因病机探微[J].中医研究,2005,18(12):2-3. 被引量:7
  • 2饶慧瑛,魏来,费然,王江华,蒋栋,张权,丛旭.干扰素β对肝星状细胞活化调控机制的影响[J].中华肝脏病杂志,2006,14(7):550-552. 被引量:9
  • 3Bang D,Yoon KH,Chung HG,et al.Epidemiological and clinical features of Behcet's disease in Korea.Yonsei Med J 1997;38(6):428-436.
  • 4Krause I,Uziel Y,Guedj D,et al.Childhood Behcet's disease:clinical features and comparison with adult-onset disease.Rheumatology (Oxford) 1999;38(5):457-462.
  • 5Krause I,Mader R,Sulkes J,et al.Behcet's disease in Israel:the influence of ethnic origin on disease expression and severity.J Rheumatol 2001;28(5):1033-1036.
  • 6Baixauli A,Calvo J,Tamarit JJ,et al.Behcet's disease:retrospective study.An Med Interna 2001;18(8):405-410.
  • 7Zouboulis CC,Kotter I,Djawari D,et al.Epidemiological features of Adamantiades-Behcet's disease in Germany and in Europe.Yonsei Med J 1997;38(6):411-422.
  • 8Shimizu T,Ehrlich GE,Inaba G,et al.Behcet disease(Behcet syndrome).Semin Arthritis Rheum 1979;8(4):223-260.
  • 9Nishiyama M,Nakae K,Umehara T.A study of familial occurrence of Behcet's disease with and without ocular lesions.Jpn J Ophthalmol 2001;45(3):313-316.
  • 10Verity DH,Vaughan RW,Madanat W,et al.Factor V Leiden mutation is associated with ocular involvement in Behcet disease.Am J Ophthalmol 1999;128(3):352-356.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部